Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CareDx, Inc. (CDNA : NSDQ)
 
 • Company Description   
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Number of Employees: 645

 
 • Price / Volume Information   
Yesterday's Closing Price: $23.27 Daily Weekly Monthly
20 Day Moving Average: 955,369 shares
Shares Outstanding: 53.22 (millions)
Market Capitalization: $1,238.46 (millions)
Beta: 0.81
52 Week High: $96.88
52 Week Low: $21.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -30.18% -20.65%
12 Week -34.54% -29.51%
Year To Date -48.83% -37.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 TOWER PLACE 9TH FLOOR
-
SOUTH SAN FRANCISCO,CA 94080
USA
ph: 415-287-2300
fax: 415-287-2450
caroline.corner@westwicke.com http://www.caredxinc.com
 
 • General Corporate Information   
Officers
Reginald Seeto - President; Chief Executive Officer and Director
Ankur Dhingra - Chief Financial Officer
Peter Maag - Director
George W. Bickerstaff - Director
Fred E. Cohen - Director

Peer Information
CareDx, Inc. (CHCR)
CareDx, Inc. (ESRX)
CareDx, Inc. (MYDP)
CareDx, Inc. (GBCS)
CareDx, Inc. (LAXAF)
CareDx, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 14167L103
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 53.22
Most Recent Split Date: (:1)
Beta: 0.81
Market Capitalization: $1,238.46 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.30 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.22 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.71
Price/Cash Flow: -
Price / Sales: 4.02
EPS Growth
vs. Year Ago Period: -3,600.00%
vs. Previous Quarter: -19.35%
Sales Growth
vs. Year Ago Period: 17.83%
vs. Previous Quarter: 0.25%
ROE
03/31/22 - -10.58
12/31/21 - -6.49
09/30/21 - -4.24
ROA
03/31/22 - -8.89
12/31/21 - -5.50
09/30/21 - -3.55
Current Ratio
03/31/22 - 6.15
12/31/21 - 5.61
09/30/21 - 6.38
Quick Ratio
03/31/22 - 5.88
12/31/21 - 5.38
09/30/21 - 6.11
Operating Margin
03/31/22 - -16.09
12/31/21 - -10.35
09/30/21 - -6.54
Net Margin
03/31/22 - -16.09
12/31/21 - -10.35
09/30/21 - -6.54
Pre-Tax Margin
03/31/22 - -16.47
12/31/21 - -10.83
09/30/21 - -6.79
Book Value
03/31/22 - 8.60
12/31/21 - 8.82
09/30/21 - 8.94
Inventory Turnover
03/31/22 - 5.93
12/31/21 - 6.01
09/30/21 - 6.20
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©